DRW Securities’s Quest Diagnostics DGX Stock Holding History

DRW Securities’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,600	Closed	-$527K	–	139
2020 Q3	$527K	Buy	+4,600	New	+$543K	0.03%	98

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

DRW Securities's DGX Position: Q1 2026 in Review

DRW Securities increased its Quest Diagnostics (DGX) stake by 13% in Q1 2026, buying an estimated $48K and bringing the position to 2,175 shares worth $426K. The position accounts for 0.01% of the portfolio, ranked #688.

DRW Securities first reported a position in DGX in Q4 2025 and has held it in 2 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

DRW Securities held 2,175 shares of Quest Diagnostics worth $426K as of Q1 2026.
DRW Securities bought 247 Quest Diagnostics shares in Q1 2026, an estimated $48K.
Quest Diagnostics made up 0.01% of DRW Securities's portfolio in Q1 2026, its #688 holding.
DRW Securities first reported a position in Quest Diagnostics in Q4 2025 and has held it in 2 quarters since.
1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.